Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Capital/Financing Update 2020

Aug 26, 2020

61700_rns_2020-08-26_656574ef-b2e9-4e24-a339-fedd1a239801.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

THRU ONLINE FILING

August26,2020

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra - (East). Mumbai-400051. Scrip Code: IPCALAB

Dear Sir,

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, 2[nd] September, 2020, inter-alia, to consider allotment of 5,00,000 equity shares of Rs. 2/each fully paid-up of the Company to the members of the Promoters / Promoter Group upon conversion of warrants issued to them at the meeting of the Board of Directors of the Company held on i[h] November, 2019 and pursuant to a resolution passed by the shareholders of the Company at the Extra Ordinary General Meeting held on 24[th] October, 2019.

Thanking you

==> picture [187 x 94] intentionally omitted <==

----- Start of picture text ----- Yours faithfullyFor Ipca Laboratories Limited~Harish KamathCorporate Counsel & Company Secretary----- End of picture text -----

Ipea Laboratories Ltd. www.ipea.eom

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 22 62105000 F:+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837